Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis
- PMID: 10722612
- PMCID: PMC97396
- DOI: 10.1128/IAI.68.4.2142-2147.2000
Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis
Abstract
Cystic fibrosis (CF) is characterized by dysfunction of the digestive and respiratory tracts resulting in generalized malnutrition and chronic respiratory infections. Chronic lung infections with Pseudomonas aeruginosa, intense neutrophil-dominated airway inflammation, and progressive lung disease are the major cause of high morbidity and mortality in CF. Here we investigated the effects of malnutrition in CF on innate lung defenses, susceptibility to P. aeruginosa colonization, and associated inflammation, using aerosol models of acute and chronic infections in normal, malnourished, and transgenic mice. CFTR(m1Unc-/-) knockout mice displayed body weight variations and showed variable pulmonary clearance of P. aeruginosa. This variability was not detected in bitransgenic CFTR(m1Unc-/-)(FABP-hCFTR) mice in which the intestinal defect had been corrected. Diet-induced protein calorie malnutrition in C57BL/6J mice resulted in impaired pulmonary clearance of P. aeruginosa. Tumor necrosis factor alpha (TNF-alpha) and nitrite levels detected upon exposure to P. aeruginosa aerosols were lower in the lungs of the malnourished C57BL/6J mice relative than in lungs of mice fed a normal diet. The role of TNF-alpha and reactive nitrogen intermediates in P. aeruginosa clearance was tested in TNF-alpha and inducible nitric oxide synthase (iNOS) knockout mice. P. aeruginosa clearance was diminished in transgenic TNF-alpha- and iNOS-deficient mice. In contrast to the effects of TNF-alpha and iNOS, gamma interferon knockout mice retained a full capacity to eliminate P. aeruginosa from the lung. Malnutrition also contributed to excessive inflammation in C57BL/6J mice upon chronic challenge with P. aeruginosa. The repeatedly infected malnourished host did not produce interleukin-10, a major anti-inflammatory cytokine absent or diminished in the bronchoalveolar fluids of CF patients. These results are consistent with a model in which defective CFTR in the intestinal tract leads to nutritional deficiency which in turn contributes to compromised innate lung defenses, bacterial colonization, and excessive inflammation in the CF respiratory tract.
Figures
Similar articles
-
Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.Pediatr Pulmonol. 2000 Nov;30(5):413-24. doi: 10.1002/1099-0496(200011)30:5<413::aid-ppul8>3.0.co;2-9. Pediatr Pulmonol. 2000. PMID: 11064433 Review.
-
Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L944-52. doi: 10.1152/ajplung.00387.2003. Epub 2004 Jul 9. Am J Physiol Lung Cell Mol Physiol. 2004. PMID: 15246977
-
Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.Infect Immun. 1998 Jan;66(1):280-8. doi: 10.1128/IAI.66.1.280-288.1998. Infect Immun. 1998. PMID: 9423869 Free PMC article.
-
Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.J Immunol. 2001 Jun 15;166(12):7410-8. doi: 10.4049/jimmunol.166.12.7410. J Immunol. 2001. PMID: 11390493
-
Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.Front Cell Infect Microbiol. 2017 Jun 30;7:243. doi: 10.3389/fcimb.2017.00243. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28713772 Free PMC article. Review.
Cited by
-
Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.Immunobiology. 2021 Jan;226(1):152034. doi: 10.1016/j.imbio.2020.152034. Epub 2020 Nov 24. Immunobiology. 2021. PMID: 33278710 Free PMC article.
-
Reactive species and pathogen antioxidant networks during phagocytosis.J Exp Med. 2019 Mar 4;216(3):501-516. doi: 10.1084/jem.20181886. Epub 2019 Feb 21. J Exp Med. 2019. PMID: 30792185 Free PMC article. Review.
-
Evidence for a Cystic Fibrosis Enteropathy.PLoS One. 2015 Oct 20;10(10):e0138062. doi: 10.1371/journal.pone.0138062. eCollection 2015. PLoS One. 2015. PMID: 26484665 Free PMC article.
-
The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease.PLoS One. 2015 Oct 15;10(10):e0140335. doi: 10.1371/journal.pone.0140335. eCollection 2015. PLoS One. 2015. PMID: 26469863 Free PMC article.
-
Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia.PLoS One. 2014 Mar 3;9(3):e90232. doi: 10.1371/journal.pone.0090232. eCollection 2014. PLoS One. 2014. PMID: 24595185 Free PMC article.
References
-
- Abman S H, Accurso F J, Bowman C M. Persistent morbidity and mortality of protein calorie malnutrition in young infants with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1986;5:393–396. - PubMed
-
- Alemzadeh R, Upchurch L, McCarthy V. Anabolic effects of growth hormone treatment in young children with cystic fibrosis. J Am Coll Nutr. 1998;17:419–424. - PubMed
-
- Benabdeslam H, Garcia I, Bellon G, Gilly R, Revol A. Biochemical assessment of the nutritional status of cystic fibrosis patients with pancreatic enzyme extracts. Am J Clin Nutr. 1998;67:817–818. - PubMed
-
- Biwersi J, Verkman A S. Functions of CFTR other than as a plasma membrane chloride channel. In: Dodge J A, Brock D J H, Widdicombe J H, editors. Cystic fibrosis-current topics. Vol. 2. Chichester, England: John Wiley & Sons Ltd.; 1994. pp. 155–171.
-
- Bonfield T L, Panuska J R, Konstan M W, Hillard K A, Hillard J B, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995;152:2111–2118. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
